72 percent of low-income, uninsured, or publicly insured women perceived financial barriers to screening
TUESDAY, July 13, 2021 (HealthDay News) — Nearly three in four low-income women cite perceived substantial financial barriers to undergoing cervical cancer screening, according to a study recently published in the Journal of Women’s Health.
Caitlin B. Biddell, from the University of North Carolina at Chapel Hill, and colleagues surveyed 702 low-income, uninsured, or publicly insured women (aged 25 to 64 years) who were not up to date on cervical cancer screening according to national guidelines. Participants were questioned about perceived financial barriers and costs related to screening.
The researchers found that 72 percent of participants perceived financial barriers to screening, including screening appointment costs (71 percent), follow-up/future treatment costs (44 percent), lost pay due to time missed from work (6 percent), and transportation costs (5 percent). Perceived costs to screening were associated with being uninsured versus publicly insured, being younger (25 to 34 years versus 50 to 64 years), being White versus Black, and not reporting income data. The perceived out-of-pocket cost of screening ranged from $0 to $1,300, with a median expected cost of $245.
“Providing greater cost transparency and access to financial assistance may reduce perceived financial barriers to screening, potentially increasing screening uptake among this underserved population,” the authors write.
Several authors disclosed financial ties to medical technology and pharmaceutical companies.
Retinal Imaging Can ID Atrial Fibrillation Years Before Diagnosis
U.S. Adults May Not Understand Their Risk for Vascular Disease
2021 to 2026 Saw Increase in State Funding for Suicide Prevention
Lower Breast, Cervical Cancer Screening Seen for Adults With Disabilities
Dense Breast Notification Linked to Increase in Use of Supplemental Ultrasound
Surveillance Colonoscopy at Five Years After Adenoma Removal Noninferior to Three Years
Mammography Trials Yield Excess-Incidence Patterns Consistent With Low Overdiagnosis
Family History of CRC Increases CRC Risk Similarly in IBD, General Population